African Union Development Agency (AUDA-NEPAD) COVID19 Webinar Series on galvanising African industrial capacity to supply pharmaceuticals and medical products

Topic: How technology transfer can advance local production to improve access of quality-assured medical products in the time of COVID-19

26th May 2020

3pm S.A.S.T / 1pm GMT


Assembly Decision {Assembly/AU/Dec.55(IV)} taken during the Abuja Summit in January 2005 requested the AU Commission to develop a Pharmaceutical Manufacturing Plan for Africa (PMPA) within the framework of the then NEPAD.

In 2012 the 19th African Union Assembly Decision {Assembly AU/Dec.442(XIX)} on AU endorsed the PMPA Business plan which provides a package of technical and policy solutions to the challenges hampering Africa’s progress to achieve the PMPA’s objective of creating a viable pharmaceutical industry that can provide in a sustainable manner the much needed essential medical products to improve public health outcomes while creating jobs, boosting research and development across the pharmaceutical manufacturing value chain and enhancing the industrial base of the continent.

The PMPA and its associated business plan, amongst other pillars, listed Access to Products and Technology as one of the pillars that makes up its suite of solutions for
operationalising the Pharmaceutical Manufacturing Plan for Africa. With the background of targeting self-sufficiency in pharmaceuticals, while ensuring quality medicines, improved health outcomes and increased access, new formulations have been promulgated as a possible solution.

Expanding the product portfolio of pharmaceutical companies by new formulations would include technology transfer, albeit only for companies that has achieved international GMP certification, and a good understanding of the process is crucial to having successful
technology transfer.

The possibility of increasing the product portfolio via technology transfer on the continent is no longer desirable, it is fast emerging as a national and continental security issue. This becomes more critical in the wake of the Covid-19 pandemic making it urgently necessary for Africa, more than ever, to look inward for solutions to curb the negative effect of the pandemic and the dependence on aid from other continents.

It is against this background that AUDA-NEPAD launched a series of webinars on 13 th April 2020 aimed at galvanising African industrial capacity to produce the much-needed pharmaceuticals and medical supplies to respond to Covid-19 and future pandemics. Three such webinars have since been conducted under specific thematic topics.

Speakers and Panelists

Keynote Speakers


Dr. Emily M. Kaine

Senior Vice President, Global Health, for USP


Mr. Joshua Setipa

Managing Director, United Nations Technology Bank for the Least Developed Countries



Mr. Tenu Avafia

Human Rights, Key Populations, Health Technology Innovation and Access UNDP


Dr. Victor Konde

Head of New Technologies and Innovation Section. Special Initiatives Division, United Nations Economic Commission for Africa

Dr Ngozwana

Dr. Skhumbuzo Ngozwana

Member of the Board the Federation of African Pharmaceutical Manufacturers Associations (FAPMA)

images (2)

Dr. Frederick Meadows

Senior. Technical Advisor, Product Supply Management & CMC at United States Pharmacopeia

Moderator & Closing Remarks

Dr. Ereck Chakauya

AUDA-NEPAD SANBio Network Manager

Dr. Janet Byaruhanga,

Dr. Janet Byaruhanga

Senior Programme Officer, Public Health, AUDA-NEPAD


The meeting will be attended by representatives from AU Member States, AU organs, RECs, UN Agencies, Civil Society organisations, Development Agencies, private sector, Academia, NGOs and the public.

Speaker Presentation Link Webinar Report Questions & Answers
Dr. Emily M. Kaine - Senior Vice President, Global Health, for USP
Mr. Joshua Setipa - Managing Director, United Nations Technology Bank for the Least Developed Countries